baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

United Therapeutics Corporation/ US91307C1027 /

2024-09-20 10:00:00 PM	Chg. +1.6700	Volume	Bid10:13:05 PM	Ask10:13:05 PM	Market Capitalization	Dividend Y.	P/E Ratio
353.0000USD	+0.48%	900,847 Turnover: 233.19 mill.	320.0000Bid Size: 100	356.0000Ask Size: 200	15.71 bill.USD	-	16.78

GlobeNewswire 08-22 Liquidia Files Litigation to Challenge Regulatory Exclusivity Blocking Access to YUTREPIA™ (treprost...

GlobeNewswire 08-19 U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with P...

GlobeNewswire 08-16 Liquidia Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific S...

GlobeNewswire 08-07 MannKind Corporation Reports 2024 Second Quarter Financial Results: Provides Clinical Development Up...

GlobeNewswire 08-07 Liquidia Corporation Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 06-18 Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)

GlobeNewswire 06-03 District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ La...

GlobeNewswire 05-13 Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 05-10 Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Con...

GlobeNewswire 04-10 Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer

GlobeNewswire 04-01 Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREP...

GlobeNewswire 03-13 Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire 03-04 Andrew Fisher Joins Verona Pharma as General Counsel

GlobeNewswire 02-27 MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical ...

GlobeNewswire 02-02 EH DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Alerts EHang (EH) Investors to Today’s L...

GlobeNewswire 02-02 EHANG INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wils...

GlobeNewswire 02-01 EH DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages EHang Holdings Limited Investors t...

GlobeNewswire 02-01 SHAREHOLDER ALERT: Levi & Korsinsky Notifies EHang Holdings Limited(EH) Investors of a Class Action ...

GlobeNewswire 01-31 Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Agains...

GlobeNewswire 01-31 EH 3-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages EHang (EH) Investors wi...

GlobeNewswire 01-29 SHAREHOLDER ALERT: Levi & Korsinsky Notifies EHang Holdings Limited (EH) Investors of a Class Action...

GlobeNewswire 01-29 DEADLINE ALERT for EH, BRBS, MVST, and EL: The Law Offices of Frank R. Cruz Reminds Investors of Cla...

GlobeNewswire 01-29 DEADLINE ALERT for EXFY, NATI, LPSN, EH: Law Offices of Howard G. Smith Reminds Investors of Class A...

GlobeNewswire 01-29 EHANG HOLDINGS LIMITED (NASDAQ: EH) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the ...

GlobeNewswire 01-27 Investor Lawsuit Alleges EHang (EH) Inflated Order Book and Hid Flight Restrictions– Hagens Berman

United Therapeutics Corporation/ US91307C1027 /

If you wish to receive reply to your feedback, please provide your email address.